Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.

OBJECTIVES Because duration of inotropic support after left ventricular assist device implantation has been recognized as a surrogate for right ventricular dysfunction, we sought to (1) identify its preimplantation risk factors, particularly its association with preimplantation right ventricular dysfunction, and (2) assess its impact on clinical outcomes. METHODS Between 1991 and 2002, left ventricular assist devices were implanted in 207 patients, exclusive of those receiving preoperative mechanical circulatory support, which precluded measuring right ventricular stroke work. Duration of inotropic support was analyzed as a continuous variable, truncated by death or transplantation, and in turn as a risk factor for these 2 events. RESULTS Inotropic support decreased from 100% on the day of implantation to 57%, 33%, and 22% by days 7, 14, and 21. Its duration was strongly associated with lower preimplantation right ventricular stroke work index, older age, and nonischemic cardiomyopathy and was associated (P < .04) with higher mortality before transplantation but not with transition to transplantation. We identified no preimplantation risk factors for right ventricular assist device use because of its relatively infrequent use in this population (18 patients, only 4 of whom survived to transplantation). CONCLUSION Duration of inotropic support after left ventricular assist device insertion is strongly correlated with low preimplantation right ventricular stroke work index. In turn, it was associated with reduced survival to transplantation. Thus, right ventricular stroke work measured before implantation might be useful in decision making for biventricular support, destination therapy, or total artificial heart.

[1]  M. Oz,et al.  Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. , 2002, The Annals of thoracic surgery.

[2]  A. Pavie,et al.  Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: a single-center 15-year experience. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  Kiyotaka Fukamachi,et al.  Predictors of Severe Right Ventricular Failure After Implantable Left Ventricular Assist Device Insertion: Analysis of 245 Patients , 2002, Circulation.

[4]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .

[5]  Leo Breiman,et al.  Bagging Predictors , 1996, Machine Learning.

[6]  S. Bolling,et al.  Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. , 1999, Circulation.

[7]  L. Wiklund,et al.  Risk factor analysis of Swedish Left Ventricular Assist Device (LVAD) patients. , 2003, The Annals of thoracic surgery.

[8]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[9]  N G Smedira,et al.  Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. , 1999, The Annals of thoracic surgery.

[10]  L. Gray,et al.  Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. , 1997, The Journal of thoracic and cardiovascular surgery.

[11]  M. Oz,et al.  Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? , 1997, Circulation.

[12]  B. Lytle,et al.  Competing risks after coronary bypass surgery: the influence of death on reintervention. , 2000, The Journal of thoracic and cardiovascular surgery.

[13]  H. A. David,et al.  The Theory of Competing Risks. , 1979 .

[14]  O H Frazier,et al.  Surgery for Acquired Cardiovascular Disease Initial experience with the AbioCor Implantable Replacement Heart System , 2004 .

[15]  R. Cody,et al.  Short-term use of intravenous milrinone for heart failure. , 1995, The American journal of cardiology.

[16]  N. Smedira,et al.  Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? , 2002, The Annals of thoracic surgery.

[17]  James W Long,et al.  Surgical management of patients in the REMATCH trial. , 2003, The Annals of thoracic surgery.

[18]  M. Oz,et al.  Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[19]  H. A. David The theory of competing risks , 1980 .

[20]  A. Pavie,et al.  Mechanical Circulatory Support for Advanced Heart Failure , 2001 .

[21]  E. Blackstone,et al.  Analysis of morbid events and risk factors for death after cardiac transplantation. , 1988, Journal of the American College of Cardiology.